Safe Supply Streaming Sees Investor Interest Surge Following Safety Strips' CEO Interview on Fentanyl- Fighting Stocks
Safe Supply Streaming Co (CSE: SPLY) reports increased investor interest following an interview with Safety Strips CEO Geoff Benic, highlighting their role in combating the opioid crisis. The opioid overdose treatment market is expected to reach $1.54 billion in 2024. Greenlane Holdings, Inc. (NASDAQ: GNLN) has partnered with Safety Strips to distribute fentanyl, xylazine, and drink-spike detection test strips across North America.
Safety Strips' products are set to launch on September 25, 2024, with shipments beginning October 1, 2024. These test strips offer a quick solution for preventing accidental overdoses and drink-spiking incidents. Safe Supply Streaming is positioned to capitalize on the growing market for safety products, with their ISO 13485 validated products. The company is exploring partnerships to expand Safety Strips' scope and develop additional tests addressing public safety needs.
Safe Supply Streaming Co (CSE: SPLY) riporta un maggiore interesse da parte degli investitori a seguito di un'intervista con il CEO di Safety Strips, Geoff Benic, che mette in evidenza il loro ruolo nella lotta contro la crisi degli oppioidi. Si prevede che il mercato del trattamento per overdose da oppioidi raggiunga $1,54 miliardi nel 2024. Greenlane Holdings, Inc. (NASDAQ: GNLN) ha collaborato con Safety Strips per distribuire strisce per il rilevamento di fentanyl, xylazine e bevande contaminate in Nord America.
I prodotti di Safety Strips saranno lanciati il 25 settembre 2024, con le spedizioni che inizieranno il 1 ottobre 2024. Queste strisce di test offrono una soluzione rapida per prevenire overdose accidentali e incidenti di contaminazione delle bevande. Safe Supply Streaming è posizionata per sfruttare il crescente mercato dei prodotti di sicurezza, grazie ai loro prodotti certificati ISO 13485. L'azienda sta esplorando partnership per espandere l'ambito di Safety Strips e sviluppare ulteriori test per rispondere alle esigenze di sicurezza pubblica.
Safe Supply Streaming Co (CSE: SPLY) informa sobre un aumento del interés de los inversores tras una entrevista con el CEO de Safety Strips, Geoff Benic, que resalta su papel en la lucha contra la crisis de los opioides. Se espera que el mercado de tratamientos para sobredosis de opioides alcance $1.54 mil millones en 2024. Greenlane Holdings, Inc. (NASDAQ: GNLN) se ha asociado con Safety Strips para distribuir tiras de prueba para detectar fentanilo, xilazina y bebidas contaminadas en América del Norte.
Los productos de Safety Strips están programados para lanzarse el 25 de septiembre de 2024, con envíos que comenzarán el 1 de octubre de 2024. Estas tiras de prueba ofrecen una solución rápida para prevenir sobredosis accidentales y incidentes de contaminación de bebidas. Safe Supply Streaming está en posición de capitalizar el creciente mercado de productos de seguridad, con productos validados por ISO 13485. La empresa está explorando asociaciones para ampliar el alcance de Safety Strips y desarrollar pruebas adicionales que aborden las necesidades de seguridad pública.
Safe Supply Streaming Co (CSE: SPLY)는 Safety Strips의 CEO인 Geoff Benic과의 인터뷰 이후 투자자들의 관심이 증가했다고 보고했습니다. 이 인터뷰는 그들의 아편유사제 위기 대응 역할을 강조합니다. 아편유사제 과다복용 치료 시장은 2024년에 15.4억 달러에 이를 것으로 예상됩니다. Greenlane Holdings, Inc. (NASDAQ: GNLN)은 Safety Strips와 협력하여 북미 전역에서 펜타닐, 자일라진 및 음료 오염 감지 테스트 스트립을 배포합니다.
Safety Strips의 제품은 2024년 9월 25일에 출시될 예정이며, 배송은 2024년 10월 1일부터 시작됩니다. 이 테스트 스트립은 우발적인 과다복용 및 음료 오염 사건을 예방하기 위한 빠른 해결책을 제공합니다. Safe Supply Streaming은 ISO 13485 인증 제품을 가지고 안전 제품의 성장하는 시장을 적극적으로 활용할 준비가 되어 있습니다. 이 회사는 Safety Strips의 범위를 확대하고 공공 안전 요구사항을 충족시키기 위한 추가 테스트를 개발하기 위해 파트너십을 탐색하고 있습니다.
Safe Supply Streaming Co (CSE: SPLY) fait état d'un intérêt accru des investisseurs suite à un entretien avec le PDG de Safety Strips, Geoff Benic, soulignant leur rôle dans la lutte contre la crise des opioïdes. Le marché du traitement des overdoses d'opioïdes devrait atteindre 1,54 milliard de dollars en 2024. Greenlane Holdings, Inc. (NASDAQ: GNLN) s'est associé à Safety Strips pour distribuer des bandelettes de test de détection de fentanyl, de xylazine et de boissons contaminées en Amérique du Nord.
Les produits de Safety Strips devraient être lancés le 25 septembre 2024, avec des expéditions commençant le 1er octobre 2024. Ces bandelettes de test offrent une solution rapide pour prévenir les overdoses accidentelles et les incidents de contamination des boissons. Safe Supply Streaming est bien positionnée pour tirer parti du marché croissant des produits de sécurité, avec ses produits validés ISO 13485. L'entreprise explore des partenariats pour étendre la portée de Safety Strips et développer des tests supplémentaires pour répondre aux besoins de sécurité publique.
Safe Supply Streaming Co (CSE: SPLY) berichtet über ein gestiegenes Interesse von Investoren nach einem Interview mit Geoff Benic, dem CEO von Safety Strips, das ihre Rolle im Kampf gegen die Opioidkrise hervorhebt. Der Markt für die Behandlung von Opioidüberdosierungen wird voraussichtlich 1,54 Milliarden Dollar im Jahr 2024 erreichen. Greenlane Holdings, Inc. (NASDAQ: GNLN) hat sich mit Safety Strips zusammengeschlossen, um Fentanyl-, Xylazin- und Getränkekontaminierungsteststreifen in Nordamerika zu vertreiben.
Die Produkte von Safety Strips werden am 25. September 2024 auf den Markt kommen, die Auslieferungen beginnen am 1. Oktober 2024. Diese Teststreifen bieten eine schnelle Lösung zur Vermeidung von versehentlichen Überdosierungen und Vorfällen von Getränkekontamination. Safe Supply Streaming ist in der Lage, vom wachsenden Markt für Sicherheitsprodukte zu profitieren, mit ihren nach ISO 13485 validierten Produkten. Das Unternehmen erkundet Partnerschaften, um den Wirkungskreis von Safety Strips zu erweitern und zusätzliche Tests zu entwickeln, die den Bedürfnissen der öffentlichen Sicherheit gerecht werden.
- Partnership with Greenlane Holdings (NASDAQ: GNLN) for distribution of detection test strips
- Launch of Safety Strips' products on September 25, 2024, with shipments starting October 1, 2024
- Potential market growth with opioid overdose treatment market expected to reach $1.54 billion in 2024
- Products validated to meet ISO 13485 standards
- Exploring partnerships to expand Safety Strips' scope and develop additional safety tests
- None.
Toronto, Ontario--(Newsfile Corp. - September 24, 2024) - Safe Supply Streaming Co Ltd. (CSE: SPLY) is pleased to see heightened investor interest following a recent interview with the CEO of Safety Strips, a Safe Supply portfolio company.
The interview with Safety Strips CEO Geoff Benic highlighted the company's active role in combating the opioid crisis through innovative drug detection technologies. With global attention on the escalating dangers of fentanyl and xylazine, investors are increasingly focusing on companies developing solutions to combat these dangerous substances.
According to a recent industry snapshot by InvestorIdeas.com, the opioid overdose treatment market is expected to reach
Innovative Solutions to Combat Fentanyl and Xylazine
Through Safety Strips Inc., Safe Supply Streaming is making significant strides in the fight against dangerous drugs. Safety Strips' highly reliable and affordable detection products are set to launch on September 25, 2024, with shipments beginning on October 1, 2024, through Greenlane's online platforms and wholesale portals. These test strips provide a quick, easy-to-use solution for consumers, offering a critical tool in preventing accidental overdoses and drink-spiking incidents.
By leveraging Greenlane's robust distribution network, Safety Strips will reach a broad audience, from individual consumers to bars and clubs that are now required by California law (Assembly Bill No. 1013) to offer drink-spiking detection kits.
Growing Market Demand and Value for Shareholders
As the demand for effective drug detection solutions rises, Safe Supply Streaming is positioned to capitalize on the growing market for safety products. The launch of Safety Strips' detection kits is expected to generate significant shareholder value, reinforcing the company's commitment to fighting the fentanyl epidemic. Safe Supply's products, validated to meet ISO 13485 standards, offer consumers peace of mind in a world where dangerous substances are becoming increasingly prevalent.
Safe Supply, Chief Executive Officer, Bill Panagiotakopoulos Comments: "We are actively exploring partnerships and engaging with key players within the medical technology ecosystem to expand the scope of Safety Strips. Our close collaboration with Geoff and his team has been instrumental in driving progress, and we're thrilled by the visibility our partner, Greenlane, has brought to this critical issue. While fentanyl detection is a significant focus, it's only the beginning. Our test strip portfolio is extensive, and we're particularly excited about several upcoming tests that will further address urgent public safety needs. We look forward to sharing more details with the market in the near future."
About Safe Supply Streaming Corp.
Safe Supply Streaming Co Ltd. (CSE: SPLY) is at the forefront of transforming the med-tech landscape, committed to leveraging innovative technologies to enhance healthcare and safety. With a strategic focus on growth and development, the company is dedicated to providing advanced solutions and driving substantial value for its stakeholders.
Investor Relations Contact:
Safe Supply Streaming Co Ltd.
Email: info@safesupply.com
Bill Panagiotakopoulos
Chief Executive Officer and Director
bill@safesupply.com
Website: www.safesupply.com
Forward-Looking Information and Statements
This news release contains "forward-looking information" and "forward-looking statements" within the meaning of applicable Canadian securities laws (collectively, "forward-looking statements"). All statements, other than statements of historical fact, are forward-looking statements, including but not limited to, statements regarding the future financial or operating performance of Safe Supply Streaming Co. Ltd. (the "Company"), its business, operations, and strategies, and the Company's future growth and plans. Forward-looking statements are generally identified by words such as "believe", "expect", "anticipate", "intend", "estimate", "plan", "may", "will", "could", "should", "would", "potential", "continue" or similar expressions.
These forward-looking statements are based on the Company's current expectations and assumptions regarding future events, including assumptions regarding general business and economic conditions, the Company's ability to execute its growth strategies, obtain necessary regulatory approvals, and access financing on reasonable terms. The Company cautions that all forward-looking statements are subject to a variety of risks and uncertainties, many of which are beyond the Company's ability to control or predict, and which could cause actual events or results to differ materially from those projected in the forward-looking statements.
Such risks and uncertainties include, but are not limited to, changes in market conditions, regulatory changes, the availability of financing, and the Company's ability to implement its business strategies effectively. Readers are cautioned not to place undue reliance on forward-looking statements as actual results may vary significantly.
The forward-looking statements contained in this press release are made as of the date hereof, and the Company undertakes no obligation to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events, or otherwise, except as required by applicable law.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/224338
FAQ
When will Safety Strips' fentanyl and xylazine detection products launch?
Who is partnering with Safety Strips to distribute their detection test strips?
What is the projected size of the opioid overdose treatment market in 2024?
What standards do Safe Supply Streaming's products meet?
